Cumulus Neuroscience Receives the US FDA’s Clearance of User-Friendly EEG Device At-Home Use for Neuropsychiatric and Neurodegenerative Conditions
Shots:
- The US FDA has granted 510(k) clearance to the novel, dry-sensor EEG headset, a user-friendly device for self-directed use & generates clinical-grade data across multiple domains of brain function from specific disease symptoms to functional neurophysiology for remote physician review
- The device is designed for adult & adolescent patients available in 4 sizes & is easily self-applied in 5 min. with guidance from the Cumulus mobile app
- The data showed that Cumulus' headset-based portable EEG technology was an effective tool for cognitive neuroscience investigations & provide objective, routine, & patient-centered tracking of biomarkers of functional neurophysiology
Ref: PR Newswire | Image: Cumulus Neuroscience
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
